KLIFO A/S: Financial statements 2022
CVR: 18196131
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
KLIFO A/S (CVR 18196131) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 132,185,000 and a net result of DKK 832,000 compared with DKK 2,838,000 the year before. That is an increase of 8.4% compared with the year before. Equity in the 2022 report amounted to DKK 15,303,000. The solvency ratio was 16.5%. The company had 143 employees in the financial year.
- Gross Profit
- DKK 132,185,000
- Profit/Loss
- DKK 832,000
- Equity
- DKK 15,303,000
- Total Assets
- DKK 92,889,000
- Employees
- 143
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 132.2M | 832K | 15.3M | 143 |
| 2021 | - | 122M | 2.8M | 21.9M | 126 |
| 2020 | - | 107.4M | 8.4M | 23.4M | 108 |
| 2019 | - | 81.1M | -263K | 14.9M | 97 |
| 2018 | - | 70.1M | 7.4M | 18.9M | 73 |
Official annual report
Keep an eye on KLIFO A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
KLIFO A/S has published its annual report for 2021. Gross profit came to DKK 121,967,000, and the net result was DKK 2,838,000.
About KLIFO A/S
KLIFO A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1994. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting BidCo ApS. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 84,066,000 and a net result of DKK -47,419,000 compared with DKK -128,000 the year before. Equity in the 2025 report amounted to DKK 16,135,000.